NanoDetection Technology Raises $2.3M in Series A Round

The funding is expected to be used for clinical trials and to fund its plans to get FDA clearance for its MRSA test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories